Regulatory round-up: 17 August 2026

Medicines regulators in major international markets have issued a mix of approvals, direct healthcare professional communications, recalls, shortage measures and procedural updates over the past week.

The latest round-up includes an accelerated approval from the US Food and Drug Administration (FDA), an oncology approval, a vaccine safety statement and a clinical trials pilot from the UK Medicines and Healthcare products Regulatory Agency (MHRA), safety communications from Swissmedic, and shortage and quality guidance from the Therapeutic Goods Administration (TGA) in Australia. The table below summarizes official human medicines regulatory updates from the past seven days.